Medicine Supply Map

USP Medicine Supply Map

As supply chains become increasingly global and complex, digital transformation is no longer optional but essential. The USP Medicine Supply Map is an innovative platform driven by advanced AI technology and predictive analytics, built to simplify and optimize supply chain management. It delivers proactive insights to identify and tackle potential risks throughout the worldwide medicine supply chain. The platform empowers manufacturers and buyers to make data-driven decisions that prevent disruptions.

When you partner with USP, you’re not only gaining access to technology, but you’re also joining an effort to strengthen the reliability and resilience of the world’s medicine supply. Together, we can build a healthier, safer future where everyone has access to the medicines they need.

How the USP Medicine Supply Map Helps You:

  • Identify vulnerable drugs: Anticipate potential shortages and ensure visibility in supply chain management.
  • Optimize inventory: Adjust stock based on real-time risk assessments.
  • Secure contracts: Ensure stability through strategic planning.
  • Unlock new opportunities: Capitalize on market shifts and forecast trends.

Why Choose USP Medicine Supply Map?

Why Choose USP Medicine Supply Map?

  • 100% predictive accuracy: Accurately predicted 100% of new injectable drug shortages in 2024 by identifying them as high-risk prior to occurrence .
  • Production & inventory optimization: Tailored forecasts provide short-term and long-term planning insights.
  • Early shortage detection: Identifies 1 in 2 injectable shortages up to 4 months before they happen.
  • Critical drug prioritization: Focus on high-impact drugs crucial to market stability.
  • Comprehensive risk mapping:
    • 94% of finished dosage forms mapped at U.S. Rx label: Tracks most prescription drug forms for supply chain insights
    • 85% of API volume mapped to facilities: Monitors APIs for supply chain transparency
    • Maps 85% of active NDCs by country of origin: Identifies where drugs are made to spot geographic supply risks

Understanding USP's Medicine Supply Map:

 

Key Features: 

  1. End-to-end supply chain mapping: Integrate data for full visibility in supply chain management.
  2. Drug shortage predictions: AI-driven forecasts predict shortages 4-12 months ahead.
  3. FDA inspection & recall updates: Monthly alerts provide key shortage signals.
  4. Quantified risk drivers: Target risks based on historical data and market conditions.
  5. Market share data: Focus on high-impact drugs at risk of shortage.
  6. Customization and flexibility: Users can tailor views, apply filters, and generate reports to meet specific needs, enhancing overall satisfaction.
  7. Dashboard: Visualize supply chain resilience and risk trends in real-time.
  8. Monthly reports & model transparency: Stay informed with regular data updates and monthly reports detailing model accuracy, false positives, and false negatives.

 

 Related Insights & Who We Serve:

2024 Drug Shortages Report

2024 Drug Shortages Report:

Identify the top medicines at risk and uncover the drivers behind persistent supply challenges, including pricing pressures, manufacturing delays, and geographic concentration.

Health systems & Hospitals

Health systems & Hospitals:

Gain early visibility into supply disruptions, offering more time for planning.

Manufacturers & 503Bs:

Get real-time data on potential risks that can impact demand and production.

GPOs & Distributors

GPOs & Distributors:

Manage drug shortage costs with continuity plans supported by real-time supply chain intelligence.  

Government

Government:

Inform policy and funding decisions to prevent drug shortages, improve resiliency, and strengthen national security.